Search

Learn about the latest guidelines for Pap tests, HPV tests, and pelvic exams — including recently updated recommendations.

… Thursday, February 14, 2019 Summary An MSK expert explains the recently updated recommendations for Pap tests, HPV tests, and pelvic exams. Regular screenings play a vital role in helping women prevent cervical cancer , which used to be one of the most common causes of death for women in the United States

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.

… Tuesday, September 25, 2018 Summary Gynecologist Deborah Goldfrank shares the facts about how hormonal birth control can affect a woman’s risk for cancer. When it comes to cancer risk, birth control sometimes gets a bad rap. “Usually when we talk about birth control and cancer, we’re talking about the

MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.

… Wednesday, August 21, 2019 Summary A new study from Memorial Sloan Kettering reports the first evidence of a bacterial species that appears to help kill dangerous microbes in the gut. Hospital-acquired infections are a major threat, especially for people whose immune systems may be compromised because

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

… Friday, April 20, 2012 Summary In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok. In

Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.

… Friday, April 1, 2011 Summary Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University. Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.

The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking are The Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College.

… Thursday, September 21, 2006 The Starr Foundation today announced that it has made a $100 million grant to create a wide-ranging cancer consortium to coordinate the efforts of five internationally renowned research institutions in the fight against cancer. Joining this ambitious undertaking are The Broad

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.

… Sunday, April 2, 2017 Summary Neratinib,  an experimental drug developed to target certain mutations that drive cancer growth, is showing promise for treating several types of cancer. The findings from a phase II study were presented at the 2017 AACR Annual Meeting . Highlights Basket trials are based

New findings could lead to a different kind of cancer drug that targets a DNA damage repair pathway called nucleotide excision repair.

… Monday, January 11, 2021 Summary A study has uncovered new findings about a DNA repair pathway called nucleotide excision repair and its role in the development of cancer. The paper also details how this defective pathway could be targeted with drugs. Memorial Sloan Kettering scientists have discovered

Learn more about DeepHeme, an artificial intelligence tool that helps doctors to diagnose blood and bone marrow cancers.

… Wednesday, June 11, 2025 Researchers at Memorial Sloan Kettering Cancer Center (MSK), the University of California, San Francisco (UCSF), and University of California, Berkeley (UC Berkeley) have developed an artificial intelligence (AI) tool called DeepHeme that can help automate the diagnosis of blood

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

… Thursday, September 6, 2018 Summary Research conducted at MSK has shown that more than 20% of people with a type of kidney cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations. This number is much higher than expected. Kidney cancer , also